FindTrial
Sign In

Pathogenesis and genetic pharmacology of urticaria

Pathogenesis and genetic pharmacology of urticaria

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023133
Enrollment
Unknown
Registered
2019-05-13
Start date
2019-05-06
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urticaria

Interventions

Cases versus normal population:antihistamine drug

Sponsors

Department of Dermatology, Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Urticaria with or not with angioedema,recurrent or nearly recurrent everyday; 2. aged 14 to 70 years male and female.

Exclusion criteria

Exclusion criteria: 1. already given antihistamine drugs in 2 weeks before study; 2. abnormal hepatic or renal function; 3. accompany with other disease or severe complications, given multiple drugs; 4. mental disorder, can't cooperate; 5. pregnant or lactation to be excluded.

Design outcomes

Primary

MeasureTime frame
Gene analysis;Intestinal flora;—

Countries

China

Contacts

Public ContactJie Li

Department of Dermatology, Xiangya Hospital, Central South University

1127114760@qq.com13677327943

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026